FinTrust Investment Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$545K Sell
8,609
-669
-7% -$43K 0.5% 41
2017
Q4
$569K Sell
9,278
-431
-4% -$27K 0.5% 41
2017
Q3
$619K Buy
+9,709
New +$567K 0.59% 33
2013
Q3
$314K Sell
6,775
-399
-6% -$17.5K 0.65% 40
2013
Q2
$321K Buy
+7,174
New +$311K 0.55% 46

Other funds holding BMY

FinTrust Investment Advisory Services's BMY Position: Q1 2018 in Review

FinTrust Investment Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 7.2% in Q1 2018, selling an estimated $43K and leaving 8,609 shares worth $545K. The position accounts for 0.5% of the portfolio, ranked #41.

FinTrust Investment Advisory Services first reported a position in BMY in Q2 2013 and has held it in 5 quarters since. The position peaked at $619K in Q3 2017. 1,747 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

  • FinTrust Investment Advisory Services held 8,609 shares of Bristol-Myers Squibb worth $545K as of Q1 2018.
  • FinTrust Investment Advisory Services sold 669 Bristol-Myers Squibb shares in Q1 2018, an estimated $43K.
  • Bristol-Myers Squibb made up 0.5% of FinTrust Investment Advisory Services's portfolio in Q1 2018, its #41 holding.
  • FinTrust Investment Advisory Services first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 5 quarters since.
  • FinTrust Investment Advisory Services's Bristol-Myers Squibb position peaked at $619K in Q3 2017.
  • 1,747 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on FinTrust Investment Advisory Services's 13F filing for Q1 2018, filed 20 Apr 2018.